Show simple item record

dc.contributor.advisornull
dc.contributor.authorRyan, Thomasen
dc.contributor.authorKelleher, Dermoten
dc.contributor.authorMc Manus, Rossen
dc.date.accessioned2013-09-04T08:49:34Z
dc.date.available2013-09-04T08:49:34Z
dc.date.issued2013en
dc.date.submitted2013en
dc.identifier.citationGrealy, R., White, M., Stordeur, P., Kelleher, D., Doherty, D.G., McManus, R., Ryan, T., Characterising cytokine gene expression signatures in patients with severe sepsis, Mediators of Inflammation, 2013, 2013, art. no. 164246en
dc.identifier.otherYen
dc.descriptionPUBLISHEDen
dc.description.abstractIntroduction. Severe sepsis in humans may be related to an underlying profound immune suppressive state. We investigated the link between gene expression of immune regulatory cytokines and the range of illness severity in patients with infection and severe sepsis. Methods. A prospective observational study included 54 ICU patients with severe sepsis, 53 patients with infection without organ failure, and 20 healthy controls. Gene expression in peripheral blood mononuclear cells (PBMC) was measured using real-time polymerase chain reaction. Results. Infection differed from health by decreased expression of the IL2, and IL23 and greater expression of IL10 and IL27. Severe sepsis differed from infection by having decreased IL7, IL23, IFN?, and TNF? gene expression. An algorithm utilising mRNA copy number for TNF?, IFN?, IL7, IL10, and IL23 accurately distinguished sepsis from severe sepsis with a receiver operator characteristic value of 0.88. Gene expression was similar with gram-positive and gram-negative infection and was similar following medical and surgical severe sepsis. Severity of organ failure was associated with serum IL6 protein levels but not with any index of cytokine gene expression in PBMCs. Conclusions. Immune regulatory cytokine gene expression in PBMC provides a robust method of modelling patients' response to infection.en
dc.description.sponsorshipThis project was supported by a Proof of Concept Grant from Enterprise Ireland, the National Development Plan of the Irish Government, and the Health Research Board of Ireland. R. Grealy is funded under the Health Research Board of Ireland Research Training Fellowship for Healthcare Professionals programme.en
dc.format.extentart. no. 164246en
dc.language.isoenen
dc.relation.ispartofseriesMediators of Inflammationen
dc.relation.ispartofseries2013en
dc.rightsYen
dc.subject.otherSepsis
dc.titleCharacterising cytokine gene expression signatures in patients with severe sepsisen
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/kellehdpen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/ryanthen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/rmcmanusen
dc.identifier.rssinternalid87970en
dc.identifier.doihttp://dx.doi.org/10.1155/2013/164246en
dc.rights.ecaccessrightsOpenAccess
dc.subject.TCDThemeGenes & Societyen
dc.subject.TCDThemeImmunology, Inflammation & Infectionen
dc.contributor.sponsorHealth Research Board (HRB)en
dc.contributor.sponsorEnterprise Irelanden
dc.identifier.urihttp://hdl.handle.net/2262/67352


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record